It has previously been shown that chest computed tomographic (CT) interpretations disagree with the TNM stage of lung cancer found at surgery in up to 40% of cases,'2 and the article by White et al in this issue of Thorax3 presents further evidence for the limited accuracy of CT scanning (pp 951-957). It seems reasonable, therefore, to ask why -despite its overall inaccuracy -chest CT scanning remains a widely used preoperative staging modality for non-small cell carcinoma of the lung. The answer is that, provided its limitations are clearly understood, chest CT scanning provides significant help in patient management for specific groups of patients.
Knowing that a tumour is totally surrounded by aerated lung and that no central lymph node enlargement or distant spread is visible on chest CT scans can be of value. Even though this information does not directly change the management, it does allow the surgeon or chest physician to discuss the prospect of surgery with the patient in simple straightforward terms, so making it easier for the patient to participate in an informed discussion about his or her management, and to await surgery with less apprehension than if the decision was based primarily on clinical and plain radiographic findings. Also, the surgeon can embark on resective surgery with a greater degree of confidence that the correct action is being taken.
Even though it is well established that normal sized intrathoracic lymph nodes -that is, nodes with a short axis diameter ofless than 10 mm -may harbour metastases, resective surgery without a properative biopsy can often be undertaken in patients whose tumours are confined to the lung and who have no enlarged mediastinal lymph nodes. The rationale for this course of action is that, since the nodes in question are not enlarged, a preoperative biopsy will necessarily be random and therefore sampling error will lead to a low yield. The findings of microscopic nodal metastases in nodes of normal size in some patients who undergo thoracotomy has to be accepted as inevitable with currently available investigations. The Currently, the only useful imaging sign of hilar/mediastinal lymph node metastases is enlargement. Neither CT density nor magnetic resonance imaging (MRI) signal intensity have proved reliable in determining or excluding metastatic involvement and gallium-67 radionuclide imaging is too insensitive and non-specific to be a routine staging test. Hope has been expressed recently that positron emission tomography with fluoro-deoxy-glucose may provide more reliable information than CT scanning,"6 but whether this proves to be the case in the long run remains to be seen.
The documented sensitivity and specificity of CT scanning for diagnosing lymph node metastases varies greatly according to the country of origin (previous fungal disease, notably histoplasmosis, in North America is a frequent incidental cause of lymph node enlargement) and the methods used to confirm the CT interpretations. As so often happens following the introduction of a new imaging technique, the early results appeared highly encouraging but when more formal studies were undertaken, including thorough sampling of all nodes whether or not they were enlarged, the accuracy proved to be much poorer. For example, early papers7-9 suggested sensitivities above 85% with acceptable specificity for diagnosing lymph node metastases. Nowadays, with more accurate pathological correlation, a reasonable generalisation is that in the USA both sensitivity and specificity are in the 50-60% range when the cutoff point for normal is a short axis diameter of 1 cm.'01' Better specificity figures have been obtained in Europe'2 and Japan,"3 presumably because the pre-valence of coincidental fungal disease is much lower than in the USA.
In the case of lymph node enlargement it is not vital to define an unequivocal cutoff point between involved and uninvolved lymph nodes, because it should be standard practice to take biopsy specimens preoperatively from the largest most accessible lymph node using the CT scan as a guide both to select the method of biopsy and to decide which nodes to sample. Mediastinoscopy provides access to the paratracheal nodes, proximal tracheobronchial nodes, and upper subcarinal nodes. The other nodal sites require alternative approaches such as anterior mediastinotomy, needle aspiration biopsy under image guidance, or transbronchoscopic biopsy. General experience shows that very large nodes -for example, those that are 3 0 cm or greater in short axis diameter-are highly likely to be involved by tumour (except, perhaps, in patients who have lived in parts ofthe world where histoplasmosis is endemic), but fortunately biopsy specimens can almost invariably be obtained from such large nodes using a relatively noninvasive needle aspiration technique.
Chest wall invasion does not necessarily preclude surgical removal, although it does adversely affect the subsequent prognosis. Diagnosing chest wall involvement by a tumour is unreliable by CT scanning, unless there is bone destruction or a large soft tissue mass.'"'7 Contact with the pleura on CT examination, even if the pleura is thickened, does not necessarily indicate invasion, although the greater the degree of contact and the greater the pleural thickening, the more likely it is that the parietal pleura has been invaded, particularly if 
